Novel siRNA compounds for inhibiting RTP801

Details for Australian Patent Application No. 2009227549 (hide)

Owner Quark Pharmaceuticals, Inc.

Inventors Skaliter, Rami; Mett, Igor; Kalinski, Hagar; Feinstein, Elena

Agent Allens Arthur Robinson

Pub. Number AU-A-2009227549

PCT Pub. Number WO2009/116037

Priority 61/070,181 20.03.08 US

Filing date 17 March 2009

Wipo publication date 24 September 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

14 October 2010 PCT application entered the National Phase

  PCT publication WO2009/116037 Priority application(s): WO2009/116037

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009227553-A marker for an ore block and a method for tracking the travel of an ore block within a stream of particulate ore material travelling along an ore travel path

2009227547-tPA mutant in the treatment of acute brain injury and neurodegenerative disorders